AVDL
Avadel Pharmaceuticals
AVDL
AVDL
78 hedge funds and large institutions have $306M invested in Avadel Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 5 closing their positions.
Holders
78
Holders Change
+4
Holders Change %
+5.41%
% of All Funds
1.95%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
10
Increased
31
Reduced
20
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Janus Henderson Group
London,
United Kingdom
|
$24.1M |
2 |
2
Renaissance Technologies
New York
|
$7.7M |
3 |
3
Millennium Management
New York
|
$8.45M |
4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$17M |
5 |
5
Morgan Stanley
New York
|
$17.3M |
Top Sellers
1 |
1
Bank of New York Mellon
New York
|
$0 |
2 |
DM
2
Deerfield Management
New York
|
$40.3M |
3 |
JGC
3
J. Goldman & Co
New York
|
$7.35M |
4 |
BC
4
Broadfin Capital
New York
|
$45.6M |
5 |
BCM
5
Brown Capital Management
Baltimore,
Maryland
|
$9.61M |